2006
Determinants of influenza vaccination in hard-to-reach urban populations
Bryant W, Ompad D, Sisco S, Blaney S, Glidden K, Phillips E, Vlahov D, Galea S, Group F. Determinants of influenza vaccination in hard-to-reach urban populations. Preventive Medicine 2006, 43: 60-70. PMID: 16684559, DOI: 10.1016/j.ypmed.2006.03.018.Peer-Reviewed Original ResearchConceptsInfluenza vaccinationRoutine medical careMedical careReceipt of healthInfluenza vaccination ratesCross-sectional studyVenue-based samplingGovernment health insuranceTime of surveyLow annual incomeVaccination ratesMultivariable modelVaccinationMinority raceHealth insuranceEast HarlemDisadvantaged urban areasReach populationsCareTotal respondentsSocial servicesParticipantsNew York CityHealthPrevious year
2005
Injection Drug Use Is an Independent Risk Factor for Iron Deficiency and Iron Deficiency Anemia Among HIV-Seropositive and HIV-Seronegative Women
Dancheck B, Tang A, Thomas A, Smit E, Vlahov D, Semba R. Injection Drug Use Is an Independent Risk Factor for Iron Deficiency and Iron Deficiency Anemia Among HIV-Seropositive and HIV-Seronegative Women. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2005, 40: 198-201. PMID: 16186738, DOI: 10.1097/01.qai.0000165909.12333.07.Peer-Reviewed Original ResearchConceptsInjection drug useIron deficiency anemiaHepatitis C virus statusFemale injection drug usersC virus statusInjection drug usersDeficiency anemiaDrug useIron deficiencyRisk factorsVirus statusDrug usersMultivariate analysisInjection drug use historyCD4 lymphocyte countHIV-seronegative womenIndependent risk factorHIV-positive womenCross-sectional studyFurther longitudinal studiesNatural history studiesIntravenous Experience (ALIVE) studyDrug use historyHIV-seropositiveLymphocyte count
2003
Factors Associated With Human Herpesvirus Type 8 Infection in an Injecting Drug User Cohort
Bernstein K, Jacobson L, Jenkins F, Vlahov D, Armenian H. Factors Associated With Human Herpesvirus Type 8 Infection in an Injecting Drug User Cohort. Sexually Transmitted Diseases 2003, 30: 199-204. PMID: 12616135, DOI: 10.1097/00007435-200303000-00004.Peer-Reviewed Original ResearchConceptsHHV-8 seroprevalenceRisk factorsHHV-8Human herpesvirus type 8 infectionLarger body mass indexHuman herpesvirus type 8Drug user cohortHHV-8 seropositivityInjection drug useBody mass indexMultivariate logistic regressionCross-sectional studyDrug user populationGenital wartsMass indexGeneral populationDrug useSeroprevalenceIndirect immunofluorescenceLogistic regressionIDUsInfectionType 8User cohortSexual behavior
2002
High Prevalence of Iron Deficiency and Anemia Among Female Injection Drug Users With and Without HIV Infection.
Semba R, Shah N, Strathdee S, Vlahov D. High Prevalence of Iron Deficiency and Anemia Among Female Injection Drug Users With and Without HIV Infection. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2002, 29: 142. PMID: 11832682, DOI: 10.1097/00042560-200202010-00005.Peer-Reviewed Original ResearchConceptsFemale injection drug usersInjection drug usersIron deficiency anemiaHIV infectionDeficiency anemiaIron deficiencyIron supplementationDrug usersHigh mortalityHepatitis C virus infectionC virus infectionHIV-negative womenHepatitis C infectionPrevalence of anemiaHepatitis C virusCross-sectional studyProgression of diseaseC infectionPlasma ferritinC virusOverall prevalenceHigh prevalenceVirus infectionAnemia patientsAnemiaHigh Prevalence of Iron Deficiency and Anemia Among Female Injection Drug Users With and Without HIV Infection
Semba R, Shah N, Strathdee S, Vlahov D. High Prevalence of Iron Deficiency and Anemia Among Female Injection Drug Users With and Without HIV Infection. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2002, 29: 142-144. DOI: 10.1097/00126334-200202010-00005.Peer-Reviewed Original ResearchFemale injection drug usersInjection drug usersIron deficiency anemiaHIV infectionDeficiency anemiaIron deficiencyIron supplementationDrug usersHigh mortalityHepatitis C virus infectionC virus infectionHIV-negative womenHepatitis C infectionPrevalence of anemiaHepatitis C virusCross-sectional studyProgression of diseaseC infectionPlasma ferritinC virusOverall prevalenceHigh prevalenceVirus infectionAnemia patientsAnemia
2001
Health care utilization among young adult injection drug users in Harlem, New York
Cronquist A, Edwards V, Galea S, Latka M, Vlahov D. Health care utilization among young adult injection drug users in Harlem, New York. Journal Of Substance Abuse 2001, 13: 17-27. PMID: 11547618, DOI: 10.1016/s0899-3289(01)00073-6.Peer-Reviewed Original ResearchConceptsYoung adult injection drug usersAdult injection drug usersInjection drug usersNeedle exchange programsHealth care utilizationCare utilizationHealth careDrug treatmentDrug usersHealth insuranceMedical careYoung injection drug usersCross-sectional studyHealth insurance coverageNEP usersUse of servicesDrug useHealth servicesAge 18Logistic regressionHealth conditionsCareInsurance coverageMonthsTreatment
2000
The prevalence of homelessness among injection drug users with and without HIV infection
Song J, Safaeian M, Strathdee S, Vlahov D, Celentano D. The prevalence of homelessness among injection drug users with and without HIV infection. Journal Of Urban Health 2000, 77: 678-687. PMID: 11194310, PMCID: PMC3456762, DOI: 10.1007/bf02344031.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusInjection drug usersInjection drug useIndependent predictorsDrug usersDrug useActive injection drug useLongitudinal cohort studyCross-sectional studyHIV/AIDSCross-sectional investigationHIV seroconversionCohort studyHIV seroprevalenceHIV infectionPrevalence of homelessnessImmunodeficiency virusMale sexLogistic regressionPrevalenceParticipantsMore experiencePredictorsSeroconversionSerostatus
1999
Sex Differences in Longitudinal Human Immunodeficiency Virus Type 1 RNA Levels among Seroconverters
Sterling T, Lyles C, Vlahov D, Astemborski J, Margolick J, Quinn T. Sex Differences in Longitudinal Human Immunodeficiency Virus Type 1 RNA Levels among Seroconverters. The Journal Of Infectious Diseases 1999, 180: 666-672. PMID: 10438353, DOI: 10.1086/314967.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus type 1 RNA levelsHIV-1 seroconvertersSex differencesCopies/mLHIV-1 pathogenesisInjection drug usersCase-control studyTime of seroconversionCross-sectional studyCourse of infectionMale patientsRapid progressorsFemale patientsCopies/Drug usersMale controlsVirus levelsPatientsRNA levelsSeroconvertersWomenMenNonprogressorsSeroconversionProgressorsHIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old
Carneiro M, Fuller C, Doherty M, Vlahov D. HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug And Alcohol Dependence 1999, 54: 83-86. PMID: 10101620, DOI: 10.1016/s0376-8716(98)00142-2.Peer-Reviewed Original ResearchConceptsInjection drug usersInjection drug useRisk behaviorsDrug usersDrug useCross-sectional studyRates of HIVHigh-risk behaviorsAge of initiationHIV infectionHIV prevalenceFirst injectionWide age rangeAverage ageNew initiatesHygiene practicesAge rangeAgeRecruitment techniquesInjectionYearsHIVInitiationInfectionPrevalenceCompliance With Universal Precautions in Correctional Health Care Facilities
Gershon R, Karkashian C, Vlahov D, Kummer L, Kasting C, Green-McKenzie J, Escamilla-Cejudo J, Kendig N, Swetz A, Martin L. Compliance With Universal Precautions in Correctional Health Care Facilities. Journal Of Occupational And Environmental Medicine 1999, 41: 181-189. PMID: 10091141, DOI: 10.1097/00043764-199903000-00007.Peer-Reviewed Original ResearchConceptsHealth care workersBloodborne exposuresUniversal precautionsCare workersCompliance rateCorrectional health care workersCorrectional health-care facilitiesBody fluid exposuresCross-sectional studyHealth care facilitiesPersonal protective equipmentCorrelates of complianceSharps disposalModifiable correlatesProtective eyewearInterventional strategiesFluid exposureCare facilitiesOverall complianceProtective equipmentCompliance ScaleFace maskAdverse working conditionsDemographic factorsExposure
1997
Vitamin A levels and human immunodeficiency virus load in injection drug users.
Semba R, Farzadegan H, Vlahov D. Vitamin A levels and human immunodeficiency virus load in injection drug users. MSphere 1997, 4: 93-5. PMID: 9008289, PMCID: PMC170483, DOI: 10.1128/cdli.4.1.93-95.1997.Peer-Reviewed Original ResearchConceptsInjection drug usersInfectious viral loadHIV viral loadPlasma vitaminViral loadDrug usersHuman immunodeficiency virus (HIV) infectionPeripheral blood mononuclear cellsHuman immunodeficiency virus loadHigher vertical transmissionLow plasma vitaminImmunodeficiency virus infectionIndependent risk factorProspective cohort studyBlood mononuclear cellsEntire study populationCross-sectional studyHIV loadQuantitative microcultureCohort studyHIV infectionMononuclear cellsRisk factorsVirus loadLow vitamin
1995
Human Immunodeficiency Virus Type 1 env and p17gag Sequence Variation in Polymerase Chain Reaction-Positive, Seronegative Injection Drug Users
Markham R, Yu X, Farzadegan H, Ray S, Vlahov D. Human Immunodeficiency Virus Type 1 env and p17gag Sequence Variation in Polymerase Chain Reaction-Positive, Seronegative Injection Drug Users. The Journal Of Infectious Diseases 1995, 171: 797-804. PMID: 7706805, DOI: 10.1093/infdis/171.4.797.Peer-Reviewed Original ResearchMeSH KeywordsAmino Acid SequenceBase SequenceCross-Sectional StudiesDNA, ViralFemaleGag Gene Products, Human Immunodeficiency VirusGene Products, envGene Products, gagGenes, envGenes, gagGenetic VariationHIV AntigensHIV InfectionsHIV-1HumansMaleMolecular Sequence DataPhylogenyPolymerase Chain ReactionSequence AlignmentSequence Analysis, DNASubstance Abuse, IntravenousViral ProteinsConceptsSeronegative injection drug usersInjection drug usersDrug usersHuman Immunodeficiency Virus Type 1 EnvCross-sectional studyPolymerase chainHIV-1 genesThird hypervariable regionAbility of virusesV3 loopMucosal surfacesIntersubject variationEnvelope regionInfected cellsAmino acid variationsEnvP17gagSeminal fluidVirusAcid variationsHypervariable regionInfectionDisease
1994
Correlates of attitudes concerning human immunodeficiency virus and acquired immunodeficiency syndrome among hospital workers
Gershon R, Curbow B, Kelen G, Celantano D, Lears K, Vlahov D. Correlates of attitudes concerning human immunodeficiency virus and acquired immunodeficiency syndrome among hospital workers. American Journal Of Infection Control 1994, 22: 293-299. PMID: 7847636, DOI: 10.1016/0196-6553(94)90016-7.Peer-Reviewed Original ResearchConceptsHigher knowledge scoresMode of transmissionGeneral AIDS knowledgeHospital workersKnowledge scoreOccupational riskAIDS knowledgeClinical workersHuman immunodeficiency virusCross-sectional studyInner-city hospitalHIV infectionImmunodeficiency syndromeAcute careImmunodeficiency virusModifiable factorsNonclinical workersHigher scoresResponse rateCorrelates of attitudesHIVAIDSLow levelsHospital employeesScores
1989
Immunological effects of HIV-1 infection on the humoral response to malaria in an African population.
Wabwire-Mangen F, Shiff C, Vlahov D, Kline R, Serwadda D, Sewankambo N, Mugerwa R, Quinn T. Immunological effects of HIV-1 infection on the humoral response to malaria in an African population. American Journal Of Tropical Medicine And Hygiene 1989, 41: 504-11. PMID: 2683820, DOI: 10.4269/ajtmh.1989.41.504.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdolescentAdultAnimalsAntibodies, ProtozoanAntigens, ProtozoanAntigens, SurfaceCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayFemaleHIV SeropositivityHIV-1HumansMalariaMaleMiddle AgedPlasmodiumPlasmodium falciparumPlasmodium malariaeProtozoan ProteinsUgandaConceptsHIV-1 infectionTrauma patientsClinical AIDSSeronegative patientsAntibody levelsHIV-1HIV-1-seronegative patientsHIV-1 seropositive patientsPolyclonal B cell activationCross-sectional studyHigh malaria transmissionB cell stimulationB cell activationSeropositive patientsImmunodeficiency syndromeMalaria antibodiesHumoral responseImmunological effectsSerological responseStudy groupPatientsCell activationMalaria transmissionControl populationLess antibody